Does Rallies show 13F holders for AEMD?

Yes. Rallies tracks hedge fund and 13F ownership data for AEMD, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AEMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AEMD. It does not provide personalized investment advice.

AEMD (AETHLON MEDICAL INC) Stock Analysis - Hedge Fund Holdings

AETHLON MEDICAL INC (AEMD) is a publicly traded Healthcare sector company. As of May 21, 2026, AEMD trades at $2.07 with a market cap of $3.20M and a P/E ratio of -0.24. AEMD moved +0.49% today. Year to date, AEMD is -24.73%; over the trailing twelve months it is -93.69%. Its 52-week range spans $1.36 to $84.40. Rallies surfaces AEMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AEMD stock?

Hedge funds tracked by Rallies that own AEMD include Two Sigma and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AETHLON MEDICAL INC.

AEMD Key Metrics

Key financial metrics for AEMD
Metric	Value
Price	$2.07
Market Cap	$3.20M
P/E Ratio	-0.24
EPS	$-8.58
Dividend Yield	0.00%
52-Week High	$84.40
52-Week Low	$1.36
Volume	304
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-13.39M
Gross Margin	0.00%

Top Hedge Funds Holding AEMD

Two Sigma holds 22.56K shares of AEMD, changed +46.13% as of Dec 31, 2024.
Two Sigma holds 13.74K shares of AEMD, changed -60.23% as of Sep 30, 2024.

Latest AEMD News

DSMB Clears Aethlon Hemopurifier for Third Cohort After Safety Review — Mar 24, 2026
Aethlon Medical Engages Maxim for Strategic Review, Finishes 2nd Trial Cohort — Mar 12, 2026
Aethlon Medical Advances Oncology Trial, Eyes SLAM Integration with $7M Cash — Feb 16, 2026
Aethlon Medical Posts $2.06M Q3 Loss, $7M Cash; Oncology Trial Cohort 2 Advances — Feb 12, 2026

AEMD Analyst Consensus

AEMD analyst coverage data. Average price target: $0.00.

Common questions about AEMD

Who owns AEMD stock?: Hedge funds tracked by Rallies that own AEMD include Two Sigma and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AETHLON MEDICAL INC.
Does Rallies show 13F holders for AEMD?: Yes. Rallies tracks hedge fund and 13F ownership data for AEMD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AEMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AEMD. It does not provide personalized investment advice.